Studies on Angiotensin Converting Enzyme Inhibitors. V. The Diastereoselective Syntheis of 2-Oxomidazolidine Derivatives
-
- KUBOTA Hitoshi
- Reserch Laboratory of Applied Biochemistry Tanabe Seiyaku Co., Ltd.
-
- NUNAMI Ken-ichi
- Reserch Laboratory of Applied Biochemistry Tanabe Seiyaku Co., Ltd.
-
- YAMAGISHI Masafumi
- Pharmaceutical Technics Division Tanabe Seiyaku Co., Ltd.
-
- NISIMOTO Sigeru
- Pharmaceutical Technics Division Tanabe Seiyaku Co., Ltd
-
- HAYASHI Kimiaki
- Reserch Laboratory of Applied Biochemistry Tanabe Seiyaku Co., Ltd.
Search this article
Abstract
A diastereoselective syntesis of imidapril (1), which is under clinical study as an antihypertensive drug based on its angiotensin converting enzyme (ACE)-inhibitory activity, was established. N-Alkylation of (2S)-2-amino-4-phenylbutyric acid ester (12) with 3-((2R)-2-methane or toluenesulfonyloxypropionyl)-2-oxoimidazolidine derivative (11) diastereoselectively proceeded in an SN2 fashion to afford tert-butyl (4S)-3-[(2S)-2-[N-[(1S)-1-ethoxycarbonyl)-3-phenylpropyl]amino]propionyl]-1-methyl-2-oxoimidazolidine-4-carboxylate (13), a precursor of 1. Alternatively, benzyl (2S)-2-[N-(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]propionate (15), which is the key building block of 13,was synthesized by teh same strategy. This procedure was also applied to the synthesis of enalapril.
Journal
-
- Chemical & pharmaceutical bulletin
-
Chemical & pharmaceutical bulletin 39 (6), 1374-1377, 1991-06-25
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1570009752554819200
-
- NII Article ID
- 110003629346
-
- NII Book ID
- AA00602100
-
- ISSN
- 00092363
-
- Text Lang
- en
-
- Data Source
-
- CiNii Articles